Cargando…
Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants
BACKGROUND: HIV remains one of the most important health issues worldwide, with almost 40 million people living with HIV. Although patients develop antibodies against the virus, its high mutation rate allows evasion of immune responses. Some patients, however, produce antibodies that are able to bin...
Autores principales: | Moore, Catherine M., Grandits, Melanie, Grünwald-Gruber, Clemens, Altmann, Friedrich, Kotouckova, Maria, Teh, Audrey Y.-H., Ma, Julian K.-C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240387/ https://www.ncbi.nlm.nih.gov/pubmed/34183026 http://dx.doi.org/10.1186/s12977-021-00560-6 |
Ejemplares similares
-
Engineering, Expression in Transgenic Plants and Characterisation of E559, a Rabies Virus-Neutralising Monoclonal Antibody
por: van Dolleweerd, Craig J., et al.
Publicado: (2014) -
Improving the efficacy of plant-made anti-HIV monoclonal antibodies for clinical use
por: Grandits, Melanie, et al.
Publicado: (2023) -
Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus
por: Berry, Jody D, et al.
Publicado: (2004) -
Engineering the N-glycosylation pathway of Nicotiana tabacum for molecular pharming using CRISPR/Cas9
por: Göritzer, Kathrin, et al.
Publicado: (2022) -
Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants
por: Teh, Audrey Y-H, et al.
Publicado: (2021)